00:00 Speaker A
We’re taking a closer look at some trending tickers this morning, and we’re doing it in 30 seconds each. We’re first identifying a team up here between Hims and Hers and Novo Nordisk. Plus, we’ve got earnings from Hilton and PayPal. First up, the healthcare team up. Pharmaceutical giant, Novo Nordisk collaborating with startup Hims and Hers to provide affordable obesity care to millions of Americans. Starting now, consumers can bundle a Hims and Hers subscription with any dose of Novo’s weight loss drug, Wegovy, for a single price starting at $599 a month.
00:43 Speaker B
Yeah, huge deal for Hims and Hers and for Novo. You can see those shares up nearly 24% and 3% for Novo as well. In earnings news, Hilton topping expectations here. If we can move ahead here, we will see that Hilton’s profit growth in the first quarter boosted its adjusted profit outlook, citing strong consumer demand. Hilton also projecting revenue per available room to be flat to up to 2% compared to 204, 2024. That’s below the previous estimate of a 2 to 3% rise.
01:20 Speaker A
Yeah, overall they remain optimistic about some of those growth opportunities. The CEO, Chris Nassetta, saying, and finally here, PayPal delivering a mixed report, earnings topping estimates while revenue missed. The company also reaffirmed its full year guidance citing macro-economic uncertainty. Shares of PYPL, you’re seeing them fractionally lower here early in trade, down by about two tenths of a percent.
01:53 Speaker B
And you can scan the QR code to track the best and worst performance stocks of the session at Yahoo Finance’s trending tickers page.